Navigation Links
RECITAL Study Presents Excellent Outcomes and Rapid Patient Recovery With Revolutionary Femoral Access Procedure
Date:12/1/2011

REDWOOD CITY, Calif., Dec. 1, 2011 /PRNewswire/ -- Clinical Investigators for Arstasis, Inc., reported the results of the RECITAL study during the recent TCT Meeting in San Francisco, demonstrating the Arstasis access device enables rapid, secure, implant-free closure of femoral arteries after cardiac catheterization procedures. The device creates a unique access pathway, called an Arstaotomy, into the femoral artery through which catheterization procedures are performed.

RECITAL is a prospective, multi-center clinical study that enrolled 351 patients to assess device and procedural success of key post-catheterization recovery measures that influence the safety and speed toward discharging those patients from the hospital. The results indicate that hospitals may be able to both reduce current complication rates and eliminate costs from longer hospitalizations in this patient population.

Key results of the RECITAL study showed that device deployment was successful in 97% of RECITAL patients and femoral bleeding stopped after only 3 minutes for diagnostic angiogram patients and 5 minutes for anti-coagulated patients undergoing a percutaneous coronary intervention (PCI). Most of the patients were able to sit up within 15-30 minutes and were able to walk in about one hour after an angiogram and two hours after a PCI. Investigators found no major complications related to use of the Arstasis device.

Dr. Dale Wortham, University of Tennessee  Medical Center, Knoxville and RECITAL Study Principal Investigator, commented, "Introducing foreign materials in a patient to close the femoral artery can be problematic. We were very pleased the RECITAL Study demonstrated the Arstaotomy procedure can deliver closure-like hemostasis and ambulation times without the use of a temporary or permanent implant."

The RECITAL Study illustrates the Arstaotomy procedure can potentially accelerate patient throughput, delivering a quicker, m
'/>"/>

SOURCE Arstasis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX® Study for Frozen Shoulder Syndrome
2. Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinsons Disease
3. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
4. BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
5. New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System
6. Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1
7. Cara Therapeutics Initiates Phase I Study with Oral Formulation of Novel Peripherally-Acting Kappa Opioid Agonist
8. Updated Survival Data from Study Comparing TTF™ (Tumor Treating Fields) Therapy to Best Standard Chemotherapy for Recurrent Glioblastoma Reported at the 16th Annual Scientific Meeting of the Society for NeuroOncology
9. Perceptive Informatics® Global Survey Results Indicate Wide Use of Industry-Standard Medical Imaging Metrics to Meet Study Milestones
10. Merrimack Pharmaceuticals Initiates Enrollment in Phase 2 Study of MM-121 in Combination with Erlotinib in Three Groups of Patients with Non-Small Cell Lung Cancer
11. goBalto Sponsors Tufts CSDD Study to Benchmark the Clinical Trial Initiation Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015  Holographic Optical Technologies of ... of holographic medical imaging, is entering the world of ... Launching on April 20 th , 2015, the campaign ... The 8-inch and 22-inch displays will allow consumers to ... first time. In addition to the two displays, the ...
(Date:3/27/2015)... -- A new report from Kalorama Information says that other ... Chile , Colombia and ... firms.  The healthcare research firm said that while ... Latin American continent with a population of over 200 million ... the country,s regional economic clout does not necessarily ensure its ...
(Date:3/27/2015)... Report Details  New study shows ... What does the future hold for top companies ... new report shows you potential revenues to 2025, assessing ... 242-page report provides 185 tables, charts, and graphs. Discover ... future market prospects. Our new study lets you assess ...
Breaking Medicine Technology:Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7
... and author on geriatrics and medical issues related ... Alzheimer,s Study Group (ASG), a new national,task force ... Gingrich and,former U.S. Senator Bob Kerrey., Dr. ... the American,Board of Internal Medicine (http://www.abim.org ), ...
... Worldwide Awareness and Funds ... Fight Aids, Tuberculosis and Malaria, SEATTLE, Nov. 28 ... distributor, today announced,the successful conclusion of "Change Me," an initiative ... thoughts on how to make the,world a better place. The ...
Cached Medicine Technology:American Board of Internal Medicine President Named to Alzheimer's Study Group 2Getty Images Celebrates Conclusion of 'Change Me' Imagery Forum 2Getty Images Celebrates Conclusion of 'Change Me' Imagery Forum 3
(Date:3/30/2015)... Mo. (PRWEB) March 30, 2015 ... a mobile library of medications used in behavioral ... for iPhone, iPad and Android—is a convenient, electronic ... annually since 1999. The useful resource provides up-to-date ... purpose, dosage and frequency, side effects, emergency conditions, ...
(Date:3/30/2015)... 2015 BioFit Engineered ... manufacturer of ergonomic seating solutions, now offers ... new upholsteries bolster the company’s existing selection ... providing disinfectable, green choices. , The BioFit ... purveyor CF Stinson. Six disinfectable patterns consisting ...
(Date:3/29/2015)... Cokato, MN (PRWEB) March 30, 2015 ... (IHRSA) Show, Helo Commercial introduced the new ... through AEC Daily. , Club owners and facilities ... 7’x8’x7’) like the new, sleek design of the Fonda ... the heater, the heater is an immediate upgrade for ...
(Date:3/29/2015)... (PRWEB) March 29, 2015 Women’s ... menopause treatment. Secondary to their location in Birmingham, ... hospital option. They continue to be affiliated with ... , Menopause is a normal condition that all ... describe any of the changes a woman goes through ...
(Date:3/29/2015)... The culmination of one of the most exciting sporting events ... invades Lucas Oil Stadium in Indianapolis IN. The 2015 ... buzzer-beaters, and of course, upsets. Throughout the dozens of games ... future professional products have been seen. In the end, it ... advanced through their regional bracket with the hopes of winning ...
Breaking Medicine News(10 mins):Health News:Popular Publication on Behavioral Health Medications Now An App 2Health News:BioFit Adds Bleachable Upholstery Options to Seating Line 2Health News:Helo Commercial Introduces Fonda Sauna Heater and Sauna and Steam Continuing Education Program at IHRSA 2Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Menopause 2Health News:Cheap 2015 Final Four Tickets: Ticket Down Slashes Kentucky Wildcats and Wisconsin Badgers Final Four Tickets at Lucas Oil Stadium and Issues Valuable Promo Code 2
... European Respiratory Society (ERS) and the European Centre for ... European Union Standards for Tuberculosis Care (ESTC). The 21 ... workers to ensure optimal diagnosis, treatment and prevention of ... TB cases in the EU/EEA in 2010 clearly showing ...
... cancer had limited side effects and in many cases ... a small-molecule oral drug, according to phase I data ... March 31 - April 4. Castration-resistant prostate cancer ... occurs when the disease progresses after treatment with androgen ...
... By Steven Reinberg HealthDay Reporter , FRIDAY, March ... two hours more in labor during childbirth than women did ... authors said several factors helped to explain the longer labors. ... ratio of weight to height) accounted for a part of ...
... FRIDAY, March 30 (HealthDay News) -- People who have ... more likely to use hospital emergency departments, a new ... is an important indicator of access to care. People ... emergency departments for medical care, said Dr. Adit Ginde, ...
... than did women 50 years ago, according to an analysis ... Institutes of Health. The researchers could not identify all of ... the change is likely due to changes in delivery room ... determine whether modern delivery practices are contributing to the increase ...
... March 30 (HealthDay News) -- The declining number of ... is cause for concern because there,s already a shortage ... has occurred for the past six years, according to ... need to provide more information and training to medical ...
Cached Medicine News:Health News:Towards TB elimination: ECDC and ERS introduce new guidelines on tuberculosis care in Europe 2Health News:Early clinical data show galeterone safe, effective against prostate cancer 2Health News:U.S. Women in Labor Longer Than They Were 50 Years Ago 2Health News:Changes in Insurance Make ER Visits More Likely: Study 2Health News:NIH study finds women spend longer in labor now than 50 years ago 2Health News:NIH study finds women spend longer in labor now than 50 years ago 3Health News:Fewer U.S. Med Students Choose Psychiatry: Report 2
Angled, 7.5 mm tying platforms.,Titanium, 111 mm long, 6 mm tying platforms....
Gills Colibri forceps, very fine pointed tips....
Castroviejo tying forceps, tying platforms, straight, 0.3 mm teeth....
Microsurgical straight forceps made of titanium has straight shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Medicine Products: